|
Volumn 47, Issue 8, 2006, Pages 1447-1448
|
Toxicity of high dose BCNU: How much is too much?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARMUSTINE;
CISPLATIN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
MELPHALAN;
ANEMIA;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
AUTOTRANSPLANTATION;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER PATIENT;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG FATALITY;
DRUG MEGADOSE;
HEMATOLOGIC MALIGNANCY;
HODGKIN DISEASE;
HUMAN;
HYPERBILIRUBINEMIA;
HYPERTENSION;
INCIDENCE;
INFECTION;
INTERSTITIAL PNEUMONIA;
KIDNEY DYSFUNCTION;
KIDNEY FAILURE;
LIVER TOXICITY;
LUNG TOXICITY;
LYMPHOMA;
MAXIMUM TOLERATED DOSE;
MENTAL DISEASE;
META ANALYSIS;
NOTE;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
SYSTEMATIC REVIEW;
THROMBOCYTOPENIA;
VEIN OCCLUSION;
WHOLE BODY RADIATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARMUSTINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MAXIMUM TOLERATED DOSE;
TRANSPLANTATION CONDITIONING;
|
EID: 33748578003
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.1080/10428190600725495 Document Type: Note |
Times cited : (3)
|
References (7)
|